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Abstract: The present study investigated the antinociceptive effects of Ocimum 
basilicum L. (Lamiaceae) leaf essential oil (LEO) and (-)-linalool (LIN) in formalin 
(2%)-, glutamate (25 μM)- and capsaicin (2.5 µg)- induced orofacial nociception 
models in mice. The involvement of these substances was further evaluated on the 
neuronal excitability of the hippocampal dentate gyrus. Male mice (n=8/group) 
were pretreated separately with LEO and by LIN (50, 100, and 200 mg/kg, i.p.), 
morphine (5 mg/kg, i.p.) and vehicle (saline + Tween 80 0.2%), before injection 
of nociceptive agent into the right upper lip (perinasal area). The LEO and LIN 
reduced the nociceptive face-rubbing behaviour in both phases on formalin test. 
LEO and LIN, at high doses, produced significantly antinociceptive effect in the 
capsaicin and glutamate tests. In hippocampal slices, LEO inhibited the population 
spike generated by stimulation of the hylus (antidromic stimulation), with an IC50 of 
0.1±0.05 mg/mL. This response was reversibly blocked by lidocaine (0.5 mg/mL), a 
known voltage-dependent sodium channel antagonist and by LIN (0.5 mg/mL). Our 
results suggest that LEO and LIN modulate neurogenic and inflammatory pain in 
the tests of orofacial nociception induced by formalin, capsaicin and glutamate. Part 
of these effects may be associated with decreased peripheral and central neuronal 
excitability. 
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Introduction
 The orofacial region is one of the most densely 
innervated (by the trigeminal nerve) areas of the body, 
which focuses some of the most common acute pains, i.e. 
those accompanying the pathological states of the teeth 
and the related structures. It is also the site of frequent 
chronic (post-herpetic neuralgia, migraine) and referred 
pains (Raboisson & Dallel, 2004). Furthermore, many of 
the diffi culties in the management of acute and chronic 
orofacial pain conditions stem from a lack of recognition 
and understanding of orofacial pain mechanisms (Miranda 
et al., 2009).
 Pain is a complex integrative phenomenon 
resulted from the integration of three components: 
sensory-discriminative, affective-emotional and 
cognitive-evaluative (Liu & Chen, 2009). When 
pain becomes chronic, the sensory dysfunction is 
accompanied by several brain disorders, such as anxiety, 
amnesia and depression (Ling et al., 2007; Narita et 
al., 2006). Cumulative behavioral, electrophysiological 
and molecular data suggested important roles for the 
hippocampal formation (HF) in pain process (Cecarelli 
et al., 1999; Liu & Chen, 2009). The main afferent 
input to the HF is the entorhinal cortex (EC), via the 
so called perforant path, which terminates on the 
dendrites of the dentate gyrus (DG). From there, the 
sensory information enters the trisynaptic hippocampal 
pathway to be processed. It is believed that this process 
is involved in the motivational dimension of pain 
(Melzak, 2008).
 The management of pain continues being a 
major challenge for medicine. Opioids, anticonvulsants 
and non-steroidal anti-inflammatory drugs (NSAIDs) 
are the main agents used to relieve acute and 
chronic pain (Pace et al., 2006). However, numerous 
therapeutic approaches are being used to better control 
the widespread clinical problem that affect a significant 
proportion of the human population (Lu et al., 2009). An 
actual approach is to develop new biological compound 
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that inhibits orofacial pain from natural products, such 
as medicinal plants or its secondary metabolites, with 
enhanced efficacy and minimal side-effects (Holanda-
Pinto et al., 2008; Quintans-Júnior et al., 2010; Siqueira 
et al., 2010).
 Essential oils are natural products generally 
obtained from medicinal plants that exhibit a variety of 
biological properties, such as analgesic (Almeida et al., 
2001), anticonvulsant (De Sousa et al., 2007; Quintans-
Júnior et al., 2008a), anxiolytic and hypnotic (Almeida 
et al., 2009). Monoterpenes are the main components of 
these essential oils and the pharmacological properties 
of many medicinal plants have been attributed to them 
(Peana et al., 2004; De Sousa et al., 2006; De Sousa et 
al., 2007; Melo et al., 2010). 
 Several Ocimum species (Lamiaceae) are 
used to treat central nervous system (CNS) disorders 
in various parts of the world and its anticonvulsant 
activity is frequently reported (Quintans-Júnior et al., 
2008b; Oliveira et al., 2009). Ocimum basilicum L. 
essential oil is rich in monoterpenes, such as δ-cadinol 
(10.2%), estragole (22.6%), and linalool (47.3%) 
(Mazutti et al., 2006). However, the major chemical 
constituent of O. basilicum essential oil, named “Maria 
Bonita” [a new variety of Ocimum derived from the 
accession PI 197442, from the Germplasm Bank North 
Central Regional PI Station (USA)] is linalool (76.93 
%) (Blank et al., 2007). (−)-Linalool is one natural 
enantiomer monoterpene compound of many essential 
oils, which is known to exhibit several biological 
activities such as CNS depressant, antinociceptive, 
anxiolytic and anticonvulsant (Peana et al., 2002; 
Peana et al., 2006; Kamatou & Viljoen, 2008; Batista et 
al., 2008). Until now, no data exists about the possible 
orofacial antinociception effect of (-)-linalool and O. 
basilicum leaf essential oil (LEO).
 The aim of this work was to evaluate the 
effect of LEO and LIN in formalin-, glutamate- and 
capsaicin-induced orofacial nociception on mice and to 
investigate if these substances could also interfere with 
the hippocampal neuronal excitability.
Material and Methods
Animals
 The experiments were conducted using male 
Swiss mice (25-32 g) and male Wistar rats (50-80 g), 
housed at 22±2 °C under a 12-h light/12-h dark cycle 
(lights on at 06:00) and with access to food and water 
ad libitum. The animals were acclimatized to the 
laboratory for at least 1 h before testing and were used 
only once throughout the experiments. The experiments 
were performed after gaining approval of the protocol 
by the Animal Care and Use Committee (CEPA/UFS 
Nº 07/08) at the Federal University of Sergipe and 
followed the current guidelines for the care of laboratory 
animals and the ethical guidelines for investigations of 
experimental pain in conscious animals (Zimmermann, 
1983). The numbers of animals (eight per group) and 
intensities of noxious stimuli used were the minimum 
necessary to demonstrate the consistent effects of the 
drug treatments. All nociception tests were carried out 
by the same visual observer.
Drug and reagents 
 For all in vivo experiments the following agents 
were used: (-)-linalool (97% purity, Sigma, USA), 
morphine hydrochloride (União Química, Brazil), 37% 
formaldehyde (Vetec, Brazil), Tween 80 (polyoxyethylene-
sorbitan monolate), glutamate and capsaicin (Sigma, USA). 
Vehicle was Tween 80 0.2% dissolved in 0.9% saline 
solution and used to dilute the test drugs. In those protocols 
the agents were injected intraperitoneally (i.p.) at a dose 
volume of 0.1 mL/10 g, with exception of algogen agents, 
such as formalin, glutamate and capsaicin, which were 
injected subcutaneously (s.c.) into the right upper lip. For 
the electrophysiological experiments the following agents 
were used: (-)-linalool, lidocaine hydrochloride (Hipolabor, 
Brazil) (0.5mg/mL) and 6,7-dinitroquinoxaline-2,3-dione 
(DNQX; 2.5µg/mL) (Sigma,USA). The LEO and LIN 
were dissolved with dimethy sulphoxide (DMSO) (Vetec, 
Brazil) and absolute ethyl alcohol (Vetec, Brazil) at a 
ratio 1:10 (v/v), and, then, diluted at 100 mL in artificial 
cerebrospinal fluid (ACSF). The DMSO and absolute ethyl 
alcohol at the concentrations used had no effect on the cell 
membrane current (Ohkubo & Kitamura, 1997; Ardjmand 
et al., 2006). Lidocaine was directly dissolved in ACSF. 
Plant material and essential oil extraction
 Leaves were collected from the cultivation of 
the Ocimum basilicum L. (Lamiaceae) (named “Maria 
Bonita”) obtained at the Research Station "Campus Rural 
da UFS" of the Federal University of Sergipe, Brazil. O. 
basilicum named “Maria Bonita” was derived from the 
accession PI 197442 of the Germplasm Bank “North 
Central Regional PI Station”, USA. It is a basil cultivar 
with a rounded canopy, rose petals and purple sepals. It is 
cultivated at Brazilian northeast region (Blank et al., 2007). 
The leaves of O. basilicum were dried in an oven with air 
renewal and circulation (model MA-037/18) at 40 °C until 
complete dehydration has been achieved. The essential 
oil was obtained by hydrodistillation in a Clevenger-type 
apparatus using 100 g of dried leaves. The O. basilicum 
leaf essential oil (LEO) obtained was dried over anhydrous 
sodium sulphate, producing yields of 4.75 mL (v/w). Gas 
chromatography-mass spectrometry (GC-MS) and gas 
chromatography-flame ionization detector (GC-FID) 
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analysis were realized to recognize the compounds of the 
LEO.
Orofacial nociception tests
 Formalin test
 Orofacial nociception was induced in mice by 
s.c. injection of 20 μL of 2% formalin into the right upper 
lip (perinasal area), using a 27-gauge needle (Clavelou 
et al., 1995; Luccarini et al., 2006). This volume and 
percentage concentration of formalin was selected from 
our pilot study that revealed a nociception-related biphasic 
behavioural response (face-rubbing) of great intensity at 
periods of 0-5 min (first phase) and 15-40 min (second 
phase). Nociception was quantified at those periods by 
measuring the time (s) that the animals spent face-rubbing 
in the injected area with its fore- or hindpaws (Luccarini 
et al., 2006). To assess the effects of test drugs, groups 
of mice (n=8, each group) were pretreated systemically 
with vehicle (tween 80 0.2% in distilled water), LEO or 
LIN (50, 100, and 200 mg/kg, i.p.), 0.5 h before the local 
injection of formalin. Morphine (MOR, 5 mg/kg, i.p.), 
administered 0.5 h before the algogen, was included as 
positive control. 
 Glutamate-induced nociception
 In an attempt to provide more direct evidence 
concerning the interaction of the LEO or LIN with 
the glutamatergic system, we separately investigated 
whether or not the LEO or LIN was able to antagonize 
glutamate-induced orofacial nociception in mice. The 
procedure used was similar to that previously described 
by Beirith et al. (2002) with some alterations, including 
the local of application according to Quintans-Júnior 
et al. (2010). A volume of 20 μL of glutamate (25 
μM/paw prepared in phosphate buffered saline) was 
injected in the right upper lip (perinasal area), using a 
27-gauge needle. Animals were observed individually 
for 15 min following glutamate injection. Nociception 
quantification was performed at this period measuring 
the time (s) that the animals spent face-rubbing the 
injected area with fore- or hindpaws. Mice (n=8, per 
group) were treated with the LEO or LIN (50, 100, and 
200 mg/kg, i.p.), morphine (MOR, 5 mg/kg, i.p.) and 
vehicle 0.5 h before glutamate injection.
 Capsaicin test
 The orofacial nociception was induced by 
capsaicin in rodents as described earlier (Pellisier et 
al., 2002). Mice (n=8, each group) were injected with 
capsaicin (20 μL, 2.5 μg) subcutaneously into the right 
upper lip (perinasal area), using a 27- gauge needle. 
Capsaicin was dissolved in ethanol, dimethyl sulfoxide 
and distilled water (1:1:8). In a pilot study, rodents 
manifested nociception-related face-rubbing behaviour 
following the injection of capsaicin with a high 
intensity at 10-20 min period. Therefore, nociception 
quantification was performed at this period measuring 
the time (s) that the animals spent face-rubbing the 
injected area with fore- or hindpaws. LEO or LIN 
(50, 100, and 200 mg/kg, i.p.) or vehicle were given 
to animals as described for formalin test, 0.5 h before 
the local injection of capsaicin. MOR (5 mg/kg, i.p.), 
administered 0.5 h before the algogen, was included 
as a positive control. An additional group received a 
similar volume of capsaicin vehicle.
Electrophysiology
 Hippocampal slice preparation
 Animals were anesthetized with ether, their 
brains were quickly removed and transferred to ACSF 
as ice cold, which was composed of (mM): NaCl 96.5; 
KC1 2.6; CaCl2 2; Mg SO4 2; NaHCO3 31.5; glucose 
10, constantly bubbled with O2 (95%) and CO2 (5%). 
The brains were glued on the base of a vibroslicer 
(WPI, USA) and cut horizontally until finding the 
hippocampi, which were sliced transversally at 400 
µm due to their anatomical position. After one hour 
of resting, the slices were transferred to the recording 
chamber (Warner, USA).
 Field potential recordings
 The field potentials were recorded on the 
cellular layer of the hippocampal dentate gyrus, using 
microelectrodes made from borosilicate glass (od: 1.5 
mm, AM-System, USA), which has resistances from 1-5 
MΩ when filled with ACSF. Stimulation (0.1 ms, 0.1-
0.3 mA, 0.05 Hz) was applied in the hylus (antidromic) 
and in the perforant path (ortodromic) with tungsten 
bipolar electrodes connected to an isolated unit, the 
Isostim A320 (WPI, USA). Field potentials were 
amplified by 100X (Axopatch1-D, Molecular Devices, 
USA), filtered at 2KHz, digitalized at 10KHz, at the 
Digidata 3220 machine (Molecular Devices, USA) and 
recorded by the WCP software (Dempster, Univ. of 
Strathclyde, Scotland).
 Pharmacological studies
 As lidocaine (0.5 mg/mL) is a dependent of 
voltage sodium channel blocker, we evaluated this 
effect using LEO (0.01, 0.1, 0.5, 1 mg/mL) and LIN 
(0.5 mg/mL) in comparison with it. These responses 
were recorded (at 0.05 Hz) for ten min or until its 
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stabilization. Then, the test substance was perfused for 
ten minutes before the field potentials were recorded. 
Unless full recovery of the control response was 
achieved, only one substance and one dose were tested 
for each slice. For the dose-response curve of the LEO, 
3-4 slices were use for each tested dose.
Statistical analysis
 For the in vivo tests, the data obtained were 
expressed as the mean ± SEM and the differences were 
evaluated by one-way analysis of variance (ANOVA) 
followed by Tukey’s test. The percent of inhibition 
by an antinociceptive agent was determined using the 
following formula (Reanmongkol et al., 1994): 
      Inhibition % = 100.(control-experiment)/control
 For the electrophysiological data, the analysis 
was performed off line with the WCP software. The 
amplitude (mV) of the field potentials were measured 
between the most negative to the most positive peak. For 
each experiment, the mean amplitude of ten responses 
before and ten minutes after the perfusion of the tested 
substances were used. Data were expressed as the mean 
± SEM. For the LEO dose-response curve, data were 
fitted by a non-linear regression sigmoidal curve, using 
the Graph Pad Prism (v 4.00) software.
Results
 GC-MS and GC-FID analysis of the essential 
oil resulted in the identification of 13 compounds, 
constituting 99.96 % of the total oil. Furthermore, 
1,8-cineole, linalool, geraniol and neryl acetate were 
the main components, comprising 96.89% of the oil. 
Linalool was the major component (76.93%) of leaves 
oil (Table 1). 
 Intraperitoneal administration of LEO or 
LIN produced a reduction in face rubbing behavior 
in formalin test (Table 2). All tested doses of LIN 
produced significantly antinociceptive effect in the first 
and second phase compared to control group (vehicle). 
LEO demonstrates, only in high dose, significantly 
antinociceptive effect in both phases. Morphine was 
able to reduce nociceptive behaviour in both phases.
 The results of the orofacial nociception induced 
by glutamate and capsaicin tests are represented in 
Table 3. Pretreatment with LIN or LEO reduced the 
neurogenic inflammatory nociception induced by 
capsaicin injection into the right upper lip (perinasal 
area). This effect was evidenced by suppression of 
the face rubbing behaviour compared with control 
group (vehicle). High doses produced a similar effect 
to morphine (5 mg/kg). Nociceptive behavior was 
no find in the control group. At the glutamate test, 
the administration of LEO or LIN (100 and 200 mg/kg, 
i.p.) decreased significantly the face rubbing behaviour 
compared with control group (vehicle).
Table 1. Volatile composition of essential oil of Ocimum 
basilicum.
Peak RT (min) Compounds
GC/MS 
(%)
GC-FID 
(%) RI 
a
1 6.967 α-tujeno 0.08 - 932
2 8.225 sabineno 0.17 - 971
3 8.392 β-pineno 0.45 0.61 976
4 10.292 1,8-cineol 6.66 6.25 1031
5 12.817 linalol 76.13 76.93 1096
6 16.333 α-terpineol 0.49 0.65 1188
7 and 8 18.342 geraniol* 11.16 11.13 1252
9 19.567 acetato de isobornila 0.15 - 1284
10 22.842 acetato de geranila 3.03 2.58 1437
11 24.675 α-trans-bergamoteno 0.96 0.88 1432
12 27.308 γ-cadineno 0.17 0.33 1512
13 31.300 epi-α-cadinol 0.55 0.60 1642
 The stimulation of the hylar region of the dentate 
gyrus (antidromic stimulation) generated a field potential 
response in the granular layer, which is characterized by 
a major negative component (population spike) followed 
by a small positive phase (Figure 1). Since this response is 
a consequence of activation of voltage-dependent sodium 
channels in the axons of the granular cells (Andersen et 
al., 1971), antagonists of these channels were expected to 
block the response. As expected, lidocaine (0.5 mg/mL) 
reversibly inhibited (about 92%) the population spike 
generated by stimulation of the hylus (Figure 1A). Similar 
effects were seen for LEO (0.5 mg/mL) (82.7±2.6 %; 
Figure 1B) and LIN (0.5 mg/mL) (63.3±0.8 %; Figure 1C). 
The effect of LEO could not be completely reversed in our 
experiments.
 The IC50 of LEO for this response was 0.1±0.05 
mg/mL as determined by the fitting with a sigmoidal 
equation of the dose-response curve (Figure 2).
 A similar field potential could be generated in 
the cellular layer by stimulation of the perforant path of 
the hippocampal slice (ortodromic stimulation). However, 
in this case the response is a consequence of glutamate 
release and glutamate receptor activation in the molecular 
layer. As shown in Figure 3A, DNQX (2.5 µmg/mL), a 
non-NMDA glutamate receptor antagonist inhibited the 
response. Similar results were seen for LEO (0.5 mg/mL) 
(Figure 3B) and linalool (0.5 mg/mL) (Figure 3C). In both 
cases the inhibitory effect was reversible.
RT: Time retention; aRI: Retention indices (Adams, 2007); *Coelution; 
the process whereby two or more chemical compounds elute from 
a chromatographic column at the same time, making separation and 
identification difficult.
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Table 2. Effect of LEO, LIN or morphine on formalin-induced the orofacial pain in mice.
Treatment Dose (mg/kg)
Face rubbing (s)
0-5 min 15-40 min
Score of paina % inhibition Score of paina % inhibition
Vehicle - 80.1±4.4 - 87.7±15.4 -
LEO 50 78.6±9.6 1.9 86.0±5.2 1.9
LEO 100 57.4±5.79b 28.3 33.1±13.5d 62.2
LEO 200 26.6±4.9d 66.8 1.7±1.4d 98.1
LIN 50 16.7±3.5d 73.9 37.7±6.8c 57.0
LIN 100 11.3±3.0d 85.9 18.6±5.1d 78.8
LIN 200 0.7±0.4d 99.1 1.7±0.4d 98.1
Morphine 5 1.7±0.5d 97.9 0.6±0.2d 99.3
n=8; aValues represent mean±SEM; bp<0.05, cp<0.01, dp<0.001 (one-way ANOVA and Tukey’s test), significantly different from control.
Table 3. Effect of LEO, LIN or morphine on glutamate- and capsaicin- induced the orofacial pain in mice.
Treatment Dose (mg/kg)
Glutamate                                                       Capsaicin
Face rubbing (s) Face rubbing (s)
Score of paina % inhibition Score of paina % inhibition
Vehicle - 53.1±6.5 - 116.3±10.3 -
LEO 50 40.1±5.6 24.5 73.0±9.6b 37.2
LEO 100 17.6±3.3c 66.9 27.1±8.3d 76.7
LEO 200 2.3±1.1d 95.7 8.3±6.7d 92.8
LIN 50 34.6±10.8 34.8 69.4±8.6c 40.3
LIN 100 25.0±5.1b 52.9 45.1±12.4d 61.2
LIN 200 17.4±5.1c 67.2 7.1±3.5d 93.9
Morphine 5 1.6±0.6d 97.0 1.4±0.5d 98.8
n=8; aValues represent mean±SEM; bp<0.05, cp<0.01, dp<0.001 (one-way ANOVA and Tukey’s test), significantly different from control.
Lidocaine 0,5 mg/mLACSF WASH
LEO 0,5 mg/mL
LIN 0,5 mg/mL
ACSF
ACSF
WASH
WASH
Figure 1. The LEO and linalool block the population spike on dentate gyrus. Representative samples of field potential recordings on 
the cellular layer of the hippocampal dentate gyrus in response to stimulation of the hylus (antidromic stimulation). Lidocaine (0.5 
mg/mL)(A), the LEO (0.5 mg/mL)(B) and linalool (0.5 mg/mL)(C) blocked the population spike of the field responses. The effect was 
reversed for lidocaine and linalool but not for the LEO. Scale bars: 5 mV and 10 ms for A and C and 3 mV and 10 ms for B.
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Discussion
 Considerable efforts have recently been made 
to discover new analgesic agents with increased efficacy 
and improved side effect profiles. A high number of 
secondary metabolites obtained from medicinal plants, 
such as monoterpenes, have been extensively studied, 
with relevant results (Calixto et al., 2000; Almeida et al., 
2001; Melo et al., 2010; Quintans-Júnior et al., 2010). In 
the present study, LEO and LIN demonstrated to play an 
antinociceptive effect using orofacial nociception tests and 
to inhibit hippocampal excitability.
 There are relatively few behavioral models in 
laboratory animals dedicated to study orofacial pain. 
Indeed, Raboisson & Dallel (2004) demonstrated that 
orofacial formalin test in rodents is a well-established 
pre-clinical model to investigate the efficacy of analgesic 
compounds in pain of the facial district. The test is based 
on a chemical stimulus (formalin) and induces a tissue 
damage that mimics acute post-injury pain in humans. 
 The orofacial formalin test is a very useful method 
for to evaluate antinociceptive drugs, and to elucidate its 
action mechanism (Luccarini et al., 2006). During the 
test, two phases can at least partially distinct mechanisms 
of nociception. The first phase is associated to direct 
stimulation of C-nociceptors, whereas the second phase 
reflects integration between peripheral (nociceptors) and 
central (spinal/ brainstem) signaling (Dallel et al., 1995; 
Capuano et al., 2009). Furthermore, it has been reported 
that the development of hyperalgesia due to injection of 
formalin involves glutamatergic system, such as N-methyl-
D-aspartate (NMDA) receptors (Beirith et al., 2002; 
Luccarini et al., 2006). Pretreatment with LEO or LIN 
were able to block both phases of the formalin response. 
The effect was more prominent to LIN.
 LIN revealed antinociceptive activity in 
acetic acid-induced visceral pain in mice; effect that 
involves activation of both opioidergic and cholinergic 
neurotransmission (Peana et al., 2003). It is well 
established that glutamate is involved in transmission 
of nociceptive signals from peripheral nervous system 
to the dorsal horn of the spinal cord. It has been reported 
that the glutamate injection elicited marked nociceptive 
responses, which is mediated by neuropeptides (such as 
substance P) released from sensory fibers and due to 
activation of glutamate receptors (i.e. NMDA). NMDA 
can stimulate the production of a variety of intracellular 
second messengers, such as nitric oxide (NO) (Carlton 
et al., 1998). Beirith et al. (2002) described that the 
nociceptive response induced by glutamate appears 
to involve peripheral, spinal and supraspinal sites of 
action and it is greatly mediated by both NMDA and 
non-NMDA receptors. In this regard, Batista et al. 
(2008) demonstrated that antinociceptive effect of LIN 
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Figure 2. The LEO blocks the population spike on dentate 
gyrus. Dose-response curve for the LEO on the negative phase 
(population spike) of the field potential response evoked by the 
hylus stimulation (antidromic stimulation). Each point on the 
graph represents the mean ± SEM of four slices. The curve is a 
non-linear regression with estimated IC50 of 0.1 mg/mL. 
LEO 0,5 mg/mLACSF WASH
LIN 0,5 mg/mLACSF WASH
ACSF DNQX 2,5 WASH
Figure 3. The LEO and linalool block the synaptic-evoked 
field response on dentate gyrus. Representative samples of field 
recordings on the cellular layer of the hippocampal dentate 
gyrus in response to perforant path stimulation (ortodromic 
stimulation). DNQX (2.5µg/mL) (A), the LEO (0.5 mg/mL) and 
linalool (0.5 mg/mL) blocked the field responses. The effect was 
reversed for the LEO and linalool. Scale bars: 3 mV and 10 ms 
for A and C and 2 mV and 10 ms for B.
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may have relationship with glutamate receptors, namely 
α-amino-3-hydroxy-5-methyl-4-isoxasolepropionic 
acid (AMPA), NMDA and kainate. Our results 
confirmed this hypothesis, since pretreatment with LIN 
significantly protected, at doses 100 and 200 mg/kg 
(i.p.), against orofacial formalin test. A similar result 
was obtained by acute administration of LEO.
 AMPA receptors mediate most fast synapses, and 
are responsible for responses to glutamate in the synapses. 
Its activation opens the channels for sodium ions, resulting 
in neuronal membrane for polarization (Sanacora et al., 
2008; Zarate & Manji, 2008). AMPA receptors play an 
integral role in brain function. Its dysregulation has been 
implacated in many neurological diseases. There are 
evidences that AMPA receptors disfunction may be one 
of the first manifestations of the synaptic dysfunction 
that underlies Alzheimer’s disease (Shepherd & Huganir, 
2007). Glutamatergic AMPA receptors are considered 
targets to suppress epileptic crisis as they have the 
property to modulate transmission induced by glutamate 
(Porto et al., 2007). The kainate receptors are associated 
with channels voltage-dependent actions and mediate 
excitatory direct and indirect modulation (Sanacora et 
al., 2008). NMDA receptors are normally blocked under 
resting conditions by the obstructing effects of Mg2+ ions. 
Since the membrane is depolarized, these receptors can 
be activated by the combined action of two molecules of 
glutamate and two molecules of glycine or D-serine. Thus, 
NMDA receptor activation serves as a functional marker 
of converging excitatory input and produces excitation 
over longer periods of time. Synaptic NMDA receptors 
activate mitogen-activated protein kinase (MAPK) and the 
transcription factor cyclic AMP-Ca2+ response element-
binding protein (CREB); induce expression of the gene 
that encodes brain-derived neurotrophic factor (BDNF); 
and promote neuronal survival (Sanacora et al., 2008).
 NMDA receptors, located in extrasynaptic 
space, act in an opposite manner, propagating signals 
that promote cell death (Sanacora et al., 2008). 
Glutamatergic system changes have been reported in 
plasma, serum, cerebrospinal fluid and brain tissue of 
affected individuals with mood disorders (Sanacora et al., 
2008). Several classes of antidepressants alter the release 
glutamatergic substances in several brain regions. Stoll et 
al. (2007) described antidepressant activity involving the 
glutamatergic system.
 LEO or LIN inhibits the neurogenic inflammatory 
pain induced by capsaicin injection into the right upper lip 
(perinasal area). Capsaicin applied to skin, muscle, and 
other tissues has been shown to produce inflammation, 
to activate and to sensitize trigeminal and spinal small-
diameter nociceptive afferents as well as dorsal horn 
neurons. It also evokes nociceptive behavior in animals 
and intense pain, hyperalgesia and referred pain in humans 
(Hu et al., 2005; Lam et al., 2009).
 The inhibitory effect observed with LEO or LIN 
on capsaicin-, and in the second phase of formalin-induced 
face rubbing behaviour may be a result of its possible 
inhibition on substance P release or due to a direct blocking 
action on its receptor neurokinin-1 (NK-1) (Holanda-Pinto 
et al., 2008). In this context, previous studies provided 
evidence for tonic activation of NK-1 receptors, through 
NK-1 receptor antagonist SR14033 administration, which 
blocked the second phase of the orofacial formalin test in 
rat (Henry et al., 1999; Luccarini et al., 2003). Waning et 
al. (2007) demonstrated that capsaicin-sensitive transient 
receptor potential vaniloid 1 (TRPV1) is one of the Ca+2 
influx channels involved in cell migration, which plays 
an important role in pain transduction. Moreover, Honda 
et al. (2008) suggest that TRPV1 receptor mechanisms in 
rat facial skin influence nociceptive responses to noxious 
cutaneous thermal and mechanical stimuli by inducing 
neuroplastic changes in subnucleus caudalis (Vc) and C1-
C2 neurons. Genetic approaches in worms, flies and mice 
have demonstrated the involvement of transient receptor 
potential (TRP) in a variety of sensory processes that 
includes thermosensation, mechanosensation, and pain 
perception (Vogt-Eisele et al., 2007). Besides, microscopic 
studies have revealed the expression of immunoreactivity 
for TRPV1 in the trigeminal ganglion (Ichikawa & 
Sugimoto, 2001; Hou et al., 2002). 
 The behavioral experiments suggest that the 
most of the analgesic effects of LEO could be attributed 
to LIN, its major component, as revealed by the GC-MS 
and GC-FID analysis. We gathered further support for this 
hypothesis in our electrophysiological results, performed 
in the hippocampal slice preparation (Figures 1, 2 and 3). 
LEO and LIN inhibited the field potentials activated by the 
antidromic stimulation of the hylus. These results suggest 
that these substances interfere with the activation of the 
voltage-dependent sodium channels present in the granular 
neurons of the hippocampal dentate gyrus (Andersen et al., 
1971). Other electrophysiological data have demonstrated 
the involvement of the hippocampal formation in pain 
processing. Khanna & Sinclair (1992) showed that noxious 
heat stimulation cause depression of hippocampal neurons 
in the area CA1. A similar effect was demonstrated with 
the formalin-induced pain model by electrophysiological 
methods (Khana & Zeng, 1999). Besides blocking action 
potential generation, LEO and LIN could interfere with 
pain process in the hippocampus as has been demonstrated 
by Khanna & Zheng (1999), using electrophysiological 
methods and by Ceccarelli et al. (1999) using the c-Fos 
immunohistochemistry.
 The DNQX 2.5 µg/mL, a non-NMDA glutamate 
receptor antagonist, inhibited the ortodromic response. 
Similar results were seen for LEO (0.5 mg/mL) and LIN 
(0.5 mg/mL). These results suggest that LEO and LIN can 
be considered a non- NMDA glutamate antagonist (AMPA 
or Kainate blokers).
LEO 0,5 mg/mLACSF WASH
LIN 0,5 mg/mLACSF WASH
ACSF DNQX 2,5 WASH
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 In conclusion, our results suggest that LEO and 
LIN modulate neurogenic and inflammatory pain in the tests 
of orofacial nociception induced by formalin, capsaicin 
and glutamate. Antinociceptive activity may be associated 
with decreased peripheral and central nerve excitability. 
Our results also support that Ocimum basilicum and 
(-)-linalool has a therapeutic potential for painful facial, 
dental disorders and a non-NMDA glutamate receptor 
antagonist.
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